Immune Checkpoint Inhibitors in the Treatment of Stage III NSCLC, Oct 23

Memo

Join us on Tuesday, October 23 at the Orlando World Center Marriott for a clinic-focused symposium during AMCP Nexus 2018. Explore the pharmacist's critical role in the optimal integration of checkpoint inhibitors into the care of patients with unresectable stage III NSCLC at this dynamic satellite. Attendees will have the opportunity to text questions to expert faculty, Ali McBride, PharmD, MS, BCOP, FAzPA; Sandra Cuellar, PharmD, BCOP; and Tarek M. Mekhail, MD, MSc, FRCSI, FRCSEd, and get practical guidance on the application of immunotherapy approaches to early-stage NSCLC. This satellite symposium is complimentary to attend and is ACPE-certified for 1.5 contact hours. For more information and to register, go to https://events.clinicaloptions.com/oncology/Nexus2018. URL:Tickets: https://go.evvnt.com/297339-0?pid=5569 Speakers: Ali McBride, PharmD, MS, BCOP, FAzPA, Sandra Cuellar, PharmD, BCOP, Tarek M. Mekhail, MD, MSc, FRCSI, FRCSEd Time: 6:00 am to 8:00 am Venue Details: Orlando World Center Marriott, 8701 World Center Drive, Orlando, 32821, United States